Align Technology/ALGN

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Align Technology

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Ticker

ALGN

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Tempe, United States

Employees

21,670

Align Technology Metrics

BasicAdvanced
$18B
Market cap
39.53
P/E ratio
$6.06
EPS
1.64
Beta
-
Dividend rate
$18B
1.64
1.226
1.017
2.529
2.529
7.02%
12.77%
39.53
4.65
4.81
5.69
41.7
5.72%
50.08%
11.63%
1.72%

What the Analysts think about Align Technology

Analyst Ratings

Majority rating from 16 analysts.
Buy

Align Technology Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.52% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$997M
4.25%
Net income
$105M
-15.32%
Profit margin
10.52%
-18.83%

Align Technology Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 8.83%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.22
$2.14
$2.42
$2.14
-
Expected
$2.03
$2.26
$2.18
$1.97
$2.31
Surprise
9.36%
-5.44%
11.16%
8.83%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Align Technology stock?

Align Technology (ALGN) has a market cap of $18B as of July 03, 2024.

What is the P/E ratio for Align Technology stock?

The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 39.53 as of July 03, 2024.

Does Align Technology stock pay dividends?

No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of July 03, 2024.

When is the next Align Technology dividend payment date?

Align Technology (ALGN) stock does not pay dividends to its shareholders.

What is the beta indicator for Align Technology?

Align Technology (ALGN) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Align Technology stock

Buy or sell Align Technology stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing